The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Yuko Wada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, 2215B Garland Ave, 1285 MRBIV, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Action Potentials, Induced Pluripotent Stem Cells, Jervell-Lange Nielsen Syndrome, KCNQ1 Potassium Channel. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Aims
While variants in KCNQ1 are the commonest cause of the congenital long QT syndrome, we and others find only a small IKs in cardiomyocytes from human-induced pluripotent stem cells (iPSC-CMs) or human ventricular myocytes. Methods and results We studied population control iPSC-CMs and iPSC-CMs from a patient with Jervell and Lange-Nielsen (JLN) syndrome due to compound heterozygous loss-of-function (LOF) KCNQ1 variants. We compared the effects of pharmacologic IKs block to those of genetic KCNQ1 ablation, using JLN cells, cells homozygous for the KCNQ1 LOF allele G643S, or siRNAs reducing KCNQ1 expression. We also studied the effects of two blockers of IKr, the other major cardiac repolarizing current, in the setting of pharmacologic or genetic ablation of KCNQ1: moxifloxacin, associated with a very low risk of drug-induced long QT, and dofetilide, a high-risk drug. In control cells, a small IKs was readily recorded but the pharmacologic IKs block produced no change in action potential duration at 90% repolarization (APD90). In contrast, in cells with genetic ablation of KCNQ1 (JLN), baseline APD90 was markedly prolonged compared with control cells (469 ± 20 vs. 310 ± 16 ms). JLN cells displayed increased sensitivity to acute IKr block: the concentration (μM) of moxifloxacin required to prolong APD90 100 msec was 237.4 [median, interquartile range (IQR) 100.6–391.6, n = 7] in population cells vs. 23.7 (17.3–28.7, n = 11) in JLN cells. In control cells, chronic moxifloxacin exposure (300 μM) mildly prolonged APD90 (10%) and increased IKs, while chronic exposure to dofetilide (5 nM) produced greater prolongation (67%) and no increase in IKs. However, in the siRNA-treated cells, moxifloxacin did not increase IKs and markedly prolonged APD90.
Conclusion
Our data strongly suggest that KCNQ1 expression modulates baseline cardiac repolarization, and the response to IKr block, through mechanisms beyond simply generating IKs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Vanderbilt University Medical Center, 2215B Garland Ave, 1285 MRBIV, Nashville, TN 37232, USA.
- Departments of Medicine, Pharmacology, and Biomedical Informatics, Vanderbilt University Medical Center, 2215B Garland Ave, 1285 MRBIV, Nashville, TN 37232, USA.
ORCID-Profile: Yuko Wada, Dan M Roden
Förderung
- NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NHGRI NIH HHS
- American Heart Association
- NIGMS NIH HHS
- Heart Rhythm Society
Zitieren
APA
Wada, Y., Wang, L., Hall, L. D., Yang, T., Short, L. L., Solus, J. F., Glazer, A. M., & Roden, D. M. (2024). The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae042
Vancouver
Wada Y, Wang L, Hall LD, Yang T, Short LL, Solus JF, et al. The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae042
BibTeX
@article{Wada2024,
author = {Wada, Yuko and Wang, Lili and Hall, Lynn D and Yang, Tao and Short, Laura L and Solus, Joseph F and Glazer, Andrew M and Roden, Dan M},
title = {The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae042}
}
EUVIMED